These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20235883)

  • 1. The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.
    Taveira-DaSilva AM; Pacheco-Rodriguez G; Moss J
    Lymphat Res Biol; 2010 Mar; 8(1):9-19. PubMed ID: 20235883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular insights into lymphangioleiomyomatosis.
    Steagall WK; Taveira-DaSilva AM; Moss J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Steagall WK; Moss J
    Cancer Control; 2006 Oct; 13(4):276-85. PubMed ID: 17075565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Moss J
    Clin Epidemiol; 2015; 7():249-57. PubMed ID: 25897262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.
    Taveira-DaSilva AM; Moss J
    Expert Opin Orphan Drugs; 2016; 4(4):369-378. PubMed ID: 27833825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangioleiomyomatosis: A review.
    Hohman DW; Noghrehkar D; Ratnayake S
    Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.
    Radzikowska E; Jaguś P; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
    Respir Med; 2015 Nov; 109(11):1469-75. PubMed ID: 26386638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.
    Meraj R; Wikenheiser-Brokamp KA; Young LR; McCormack FX
    Semin Respir Crit Care Med; 2012 Oct; 33(5):486-97. PubMed ID: 23001803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Stylianou MP; Hedin CJ; Kristof AS; Avila NA; Rabel A; Travis WD; Moss J
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1427-31. PubMed ID: 12958050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Hedin C; Stylianou MP; Travis WD; Matsui K; Ferrans VJ; Moss J
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1072-6. PubMed ID: 11587999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangioleiomyomatosis.
    Johnson SR
    Eur Respir J; 2006 May; 27(5):1056-65. PubMed ID: 16707400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
    Glasgow CG; El-Chemaly S; Moss J
    Eur Respir Rev; 2012 Sep; 21(125):196-206. PubMed ID: 22941884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangioleiomyomatosis and tuberous sclerosis complex.
    Chorianopoulos D; Stratakos G
    Lung; 2008; 186(4):197-207. PubMed ID: 18408969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Lymphangioleiomyomatosis: A Case Report and Literature Review.
    Sathirareuangchai S; Shimizu D; Vierkoetter KR
    Hawaii J Health Soc Welf; 2020 Jul; 79(7):224-229. PubMed ID: 32666056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lung lymphangioleiomyomatosis (LAM)].
    Cukić V; Lovre V; Beslić S; Bilalović N; Guska S
    Med Arh; 2008; 62(3):180-2. PubMed ID: 18822952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.
    Crausman RS; Lynch DA; Mortenson RL; King TE; Irvin CG; Hale VA; Newell JD
    Chest; 1996 Jan; 109(1):131-7. PubMed ID: 8549175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary lymphangioleiomyomatosis: report of one case].
    Silva O R; Puelma C F; Retamal P V; Rojas Sm P; Cruzat C C; Reyes G C
    Rev Med Chil; 2009 Nov; 137(11):1474-7. PubMed ID: 20098807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
    Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
    Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.